FDA.reportPublic FDA data

EQUATE HEMORRHOID RELIEF CREAM- LIDOCAINE 5%

Manufacturer
WALMART, INC
Effective date
2025-10-08
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 01:38:24

Label at a glance#

ProductEQUATE HEMORRHOID RELIEF
Active ingredientLIDOCAINE
Label structure9 sections

Indications and uses

helps relieve the pain, itching, and burning, associated with hemorrhoids and anorectal disorders.

Dosage and administration

Adult and children 12 years and over: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. apply externally to the affected area up to 6 times a day children under 12 years of age: consult a doctor.

Storage and handling

Store between 15°-30° C (59°-30° F)

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 5% W/W

PURPOSE

OTC - PURPOSE SECTION

Local Anesthetic

USES

INDICATIONS & USAGE SECTION

helps relieve the pain, itching, and burning, associated with hemorrhoids and anorectal disorders.

WARNINGS

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • use only as directed
  • avoid contact with eyes
  • do not exceed recommended dosage unless directed by a doctor
  • do not put this product into the rectum by using fingers or any mechanical device or applicator

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • rectal bleeding occurs
  • condition worsens or does not improve within 7 days
  • symptoms clear up and occur again within a few days
  • an allergic reaction develops to ingredients in this product
  • symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children and pets.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adult and children 12 years and over:

  • when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
  • apply externally to the affected area up to 6 times a day

children under 12 years of age: consult a doctor.

OTHER INFORMATION

STORAGE AND HANDLING SECTION

Store between 15°-30° C (59°-30° F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Benzyl Alcohol, Carbomer 940, Cholesterol, Isopropyl Myristate, Lecithin (Soya), Polysorbate 80, Propylene Glycol, Purified Water, Triethanolamine, Vitamin-E Acetate

QUESTIONS

OTC - QUESTIONS SECTION

1-888-287-1915

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANELPRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1366789lidocaine 5 % Rectal CreamPSN6
1366789lidocaine 50 MG/ML Rectal CreamSCD6
1366789lidocaine 5 % Rectal CreamSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
79903-109-302024-03-11C16284748780-11030e365-6d65-111a-e063-dadaa90a10e2EQUATE HEMORRHOID RELIEF CREAM- LIDOCAINE 5%
79903-109-302024-03-11C16284748780-11030e365-6d65-111a-e063-dadaa90a10e2EQUATE HEMORRHOID RELIEF CREAM- LIDOCAINE 5%
79903-109-302024-01-30C16284748780-11030e365-6d65-111a-e063-dadaa90a10e2EQUATE HEMORRHOID RELIEF CREAM- LIDOCAINE 5%
79903-109-302024-01-30C16284748780-11030e365-6d65-111a-e063-dadaa90a10e2EQUATE HEMORRHOID RELIEF CREAM- LIDOCAINE 5%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79903-109-30EQUATE HEMORRHOID RELIEF30 g in 1 TUBECREAM306
79903-109-30EQUATE HEMORRHOID RELIEF1 in 1 CARTONCREAM16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
79903-109-30GM - Gram79903-1090ca928e3-d91b-42c9-8e3f-c92d27ef9ada12024-09-09

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79903-10979903-109-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
PROPYLENE GLYCOL6DC9Q167V3IACT
WATER059QF0KO0RIACT
POLYSORBATE 806OZP39ZG8HIACT
TROLAMINE9O3K93S3TKIACT
HYDROGENATED SOYBEAN LECITHINH1109Z9J4NIACT
LIDOCAINE98PI200987ACTIB
BENZYL ALCOHOLLKG8494WBHIACT
CARBOMER 9404Q93RCW27EIACT
ALPHA-TOCOPHEROL ACETATE9E8X80D2L0IACT
CHOLESTEROL97C5T2UQ7JIACT
ISOPROPYL MYRISTATE0RE8K4LNJSIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
52025-01-09full-release2026-06-01 00:52:20

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EQUATE HEMORRHOID RELIEFLIDOCAIN 5%WALMART, INCd96e8152-e36e-22fc-e053-2995a90a8b2b2025-10-08WarningsExact identifier
ndc (package): 79903-109-30
ndc (product): 79903-109
ndc11 (package): 79903010930
spl id: 40aa11d6-d0e4-d2a6-e063-6394a90af389
spl set id: d96e8152-e36e-22fc-e053-2995a90a8b2b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.